79180936 - ORPHAZYME

Information

• Trademark
• 79180936

• Source

• Serial Number

  79180936

• Registration Number

  5139414

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 01, 2015
  8 years ago

• Registration Date

  February 14, 2017
  7 years ago

• Transaction Date

  May 27, 2024
  5 months ago

• Status Date

  August 25, 2023
  a year ago

• Published for Opposition Date

  November 29, 2016
  7 years ago

• Location Date

  February 14, 2017
  7 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEE, DOUGLAS M

• Attorney Docket Number

  336232-20024

  Attorney Name

  John Paul Oleksiuk

  Law Office Assigned Location Code

  M20

• Owners

  • ORPHAZYME APS C/O COBIS A/S
  • ORPHAZYME A/S

Case File Statements

• GS0051: Pharmaceutical and medical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; chemical-pharmaceutical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; diagnostic preparations for medical purposes; reagents for medical purposes and for research; preparations for analysis for medical and research purposes for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; all of the aforementioned with the exclusion of veterinary preparations and ingredients, supplements for food, and medicated foodstuffs for animals
• GS0011: Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; with the exclusion of chemicals used in the food industry and animal food industry and ingredients for foodstuffs for animals
• GS0421: Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector

Case File Event Statements

• 1/21/2016 - 8 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 1/28/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/2/2016 - 8 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/21/2016 - 8 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/25/2016 - 8 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/25/2016 - 8 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/26/2016 - 8 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/28/2016 - 8 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/28/2016 - 8 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/13/2016 - 8 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/26/2016 - 8 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/2/2016 - 8 years ago

  12 - ASSIGNED TO LIE Type: ALIE

• 10/5/2016 - 8 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/5/2016 - 8 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/22/2016 - 8 years ago

  16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/9/2016 - 8 years ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/29/2016 - 7 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/29/2016 - 7 years ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/22/2016 - 7 years ago

  20 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/14/2017 - 7 years ago

  21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/2/2017 - 7 years ago

  22 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/14/2017 - 7 years ago

  23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 6/1/2017 - 7 years ago

  25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/23/2017 - 7 years ago

  26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 8/31/2017 - 7 years ago

  27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/18/2016 - 8 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/1/2017 - 7 years ago

  24 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/7/2018 - 6 years ago

  29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/25/2019 - 5 years ago

  30 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/25/2019 - 5 years ago

  31 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/5/2021 - 3 years ago

  32 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 5/5/2021 - 3 years ago

  33 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 5/5/2021 - 3 years ago

  34 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/5/2021 - 3 years ago

  35 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 5/5/2021 - 3 years ago

  36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/5/2021 - 3 years ago

  37 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/8/2021 - 3 years ago

  38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/8/2021 - 3 years ago

  39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/8/2021 - 3 years ago

  40 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 6/8/2021 - 3 years ago

  41 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 6/8/2021 - 3 years ago

  42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/14/2022 - 2 years ago

  44 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 7/10/2022 - 2 years ago

  45 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 4/25/2024 - 6 months ago

  47 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 5/6/2024 - 6 months ago

  48 - INVALIDATION PROCESSED Type: INPC

• 5/6/2024 - 6 months ago

  49 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 5/27/2024 - 5 months ago

  50 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 8/25/2023 - a year ago

  46 - CANCELLED SECTION 71 Type: C71T

• 3/30/2018 - 6 years ago

  28 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 6/12/2021 - 3 years ago

  43 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP